The Lectin Pathway of Complement Activation Is a Critical Component of the Innate Immune Response to Pneumococcal Infection
The complement system plays a key role in host defense against pneumococcal infection. Three different pathways, the classical, alternative and lectin pathways, mediate complement activation. While there is limited information available on the roles of the classical and the alternative activation pathways of complement in fighting streptococcal infection, little is known about the role of the lectin pathway, mainly due to the lack of appropriate experimental models of lectin pathway deficiency. We have recently established a mouse strain deficient of the lectin pathway effector enzyme mannan-binding lectin associated serine protease-2 (MASP-2) and shown that this mouse strain is unable to form the lectin pathway specific C3 and C5 convertases. Here we report that MASP-2 deficient mice (which can still activate complement via the classical pathway and the alternative pathway) are highly susceptible to pneumococcal infection and fail to opsonize Streptococcus pneumoniae in the none-immune host. This defect in complement opsonisation severely compromises pathogen clearance in the lectin pathway deficient host. Using sera from mice and humans with defined complement deficiencies, we demonstrate that mouse ficolin A, human L-ficolin, and collectin 11 in both species, but not mannan-binding lectin (MBL), are the pattern recognition molecules that drive lectin pathway activation on the surface of S. pneumoniae. We further show that pneumococcal opsonisation via the lectin pathway can proceed in the absence of C4. This study corroborates the essential function of MASP-2 in the lectin pathway and highlights the importance of MBL-independent lectin pathway activation in the host defense against pneumococci.
Vyšlo v časopise:
The Lectin Pathway of Complement Activation Is a Critical Component of the Innate Immune Response to Pneumococcal Infection. PLoS Pathog 8(7): e32767. doi:10.1371/journal.ppat.1002793
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1002793
Souhrn
The complement system plays a key role in host defense against pneumococcal infection. Three different pathways, the classical, alternative and lectin pathways, mediate complement activation. While there is limited information available on the roles of the classical and the alternative activation pathways of complement in fighting streptococcal infection, little is known about the role of the lectin pathway, mainly due to the lack of appropriate experimental models of lectin pathway deficiency. We have recently established a mouse strain deficient of the lectin pathway effector enzyme mannan-binding lectin associated serine protease-2 (MASP-2) and shown that this mouse strain is unable to form the lectin pathway specific C3 and C5 convertases. Here we report that MASP-2 deficient mice (which can still activate complement via the classical pathway and the alternative pathway) are highly susceptible to pneumococcal infection and fail to opsonize Streptococcus pneumoniae in the none-immune host. This defect in complement opsonisation severely compromises pathogen clearance in the lectin pathway deficient host. Using sera from mice and humans with defined complement deficiencies, we demonstrate that mouse ficolin A, human L-ficolin, and collectin 11 in both species, but not mannan-binding lectin (MBL), are the pattern recognition molecules that drive lectin pathway activation on the surface of S. pneumoniae. We further show that pneumococcal opsonisation via the lectin pathway can proceed in the absence of C4. This study corroborates the essential function of MASP-2 in the lectin pathway and highlights the importance of MBL-independent lectin pathway activation in the host defense against pneumococci.
Zdroje
1. MillerEWaightPEfstratiouABrissonMJohnsonA 2000 Epidemiology of invasive and other pneumococcal disease in children in england and wales 1996–1998. Acta Paediatr Suppl 89 11 16
2. KyawMHChristiePClarkeSCMooneyJDAhmedS 2003 Invasive pneumococcal disease in scotland, 1999–2001: Use of record linkage to explore associations between patients and disease in relation to future vaccination policy. Clin Infect Dis 37 1283 1291
3. BruynGAZegersBJvan FurthR 1992 Mechanisms of host defense against infection with streptococcus pneumoniae. Clin Infect Dis 14 251 262
4. SchwaebleWDahlMRThielSStoverCJenseniusJC 2002 The mannan-binding lectin-associated serine proteases (MASPs) and MAp19: Four components of the lectin pathway activation complex encoded by two genes. Immunobiology 205 455 466
5. FujitaT 2002 Evolution of the lectin-complement pathway and its role in innate immunity. Nat Rev Immunol 2 346 353
6. SchwaebleWJLynchNJClarkJEMarberMSamaniNJ 2011 Targeting of mannan-binding lectin-associated serine protease-2 confers protection from myocardial and gastrointestinal ischemia/reperfusion injury. Proc Natl Acad Sci U S A 108 7523 7528
7. GirijaUVMitchellDARoscherSWallisR 2011 Carbohydrate recognition and complement activation by rat ficolin-B. Eur J Immunol 41 214 223
8. LiuYEndoYIwakiDNakataMMatsushitaM 2005 Human M-ficolin is a secretory protein that activates the lectin complement pathway. J Immunol 175 3150 3156
9. HansenSSelmanLPalaniyarNZieglerKBrandtJ 2010 Collectin 11 (CL-11, CL-K1) is a MASP-1/3-associated plasma collectin with microbial-binding activity. J Immunol 185 6096 6104
10. ThielSVorup-JensenTStoverCMSchwaebleWLaursenSB 1997 A second serine protease associated with mannan-binding lectin that activates complement. Nature 386 506 510
11. StoverCMThielSThelenMLynchNJVorup-JensenT 1999 Two constituents of the initiation complex of the mannan-binding lectin activation pathway of complement are encoded by a single structural gene. J Immunol 162 3481 3490
12. TakahashiMEndoYFujitaTMatsushitaM 1999 A truncated form of mannose-binding lectin-associated serine protease (MASP)-2 expressed by alternative polyadenylation is a component of the lectin complement pathway. Int Immunol 11 859 863
13. IwakiDKannoKTakahashiMEndoYLynchNJ 2006 Small mannose-binding lectin-associated protein plays a regulatory role in the lectin complement pathway. J Immunol 177 12 8626 8632
14. DegnSEHansenAGSteffensenRJacobsenCJenseniusJC 2009 MAp44, a human protein associated with pattern recognition molecules of the complement system and regulating the lectin pathway of complement activation. J Immunol 183 7371 7378
15. SkjoedtMOHummelshojTPalarasahYHonoreCKochC 2010 A novel mannose-binding lectin/ficolin-associated protein is highly expressed in heart and skeletal muscle tissues and inhibits complement activation. J Biol Chem 285 8234 8243
16. Vorup-JensenTPetersenSVHansenAGPoulsenKSchwaebleW 2000 Distinct pathways of mannan-binding lectin (MBL)- and C1-complex autoactivation revealed by reconstitution of MBL with recombinant MBL-associated serine protease-2. J Immunol 165 2093 2100
17. RossiVCsehSBallyIThielensNMJenseniusJC 2001 Substrate specificities of recombinant mannan-binding lectin-associated serine proteases-1 and -2. J Biol Chem 276 40880 40887
18. TakahashiMIwakiDKannoKIshidaYXiongJ 2008 Mannose-binding lectin (MBL)-associated serine protease (MASP)-1 contributes to activation of the lectin complement pathway. J Immunol 180 6132 6138
19. KocsisAKekesiKASzaszRVeghBMBalczerJ 2010 Selective inhibition of the lectin pathway of complement with phage display selected peptides against mannose-binding lectin-associated serine protease (MASP)-1 and -2: Significant contribution of MASP-1 to lectin pathway activation. J Immunol 185 4169 4178
20. TakahashiMIwakiDKannoKIshidaYXiongJ 2008 Mannose-binding lectin (MBL)-associated serine protease (MASP)-1 contributes to activation of the lectin complement pathway. J Immunol 180 6132 6138
21. IwakiDKannoKTakahashiMEndoYMatsushitaM 2011 The role of mannose-binding lectin-associated serine protease-3 in activation of the alternative complement pathway. J Immunol 187 3751 3758
22. BrownJSHussellTGillilandSMHoldenDWPatonJC 2002 The classical pathway is the dominant complement pathway required for innate immunity to streptococcus pneumoniae infection in mice. Proc Natl Acad Sci U S A 99 16969 16974
23. AtkinsonJPFrankMM 2006 Bypassing complement: Evolutionary lessons and future implications. J Clin Invest 116 1215 1218
24. SelanderBMartenssonUWeintraubAHolmstromEMatsushitaM 2006 Mannan-binding lectin activates C3 and the alternative complement pathway without involvement of C2. J Clin Invest 116 1425 1434
25. GarredPLarsenFMadsenHOKochC 2003 Mannose-binding lectin deficiency–revisited. Mol Immunol 40 73 84
26. LiJGloverDTSzalaiAJHollingsheadSKBrilesDE 2007 PspA and PspC minimize immune adherence and transfer of pneumococci from erythrocytes to macrophages through their effects on complement activation. Infect Immun 75 5877 5885
27. Dieudonne-VatranAKrentzSBlomAMMeriSHenriques-NormarkB 2009 Clinical isolates of streptococcus pneumoniae bind the complement inhibitor C4b-binding protein in a PspC allele-dependent fashion. J Immunol 182 7865 7877
28. KrarupASorensenUBMatsushitaMJenseniusJCThielS 2005 Effect of capsulation of opportunistic pathogenic bacteria on binding of the pattern recognition molecules mannan-binding lectin, L-ficolin, and H-ficolin. Infect Immun 73 1052 1060
29. ShiLTakahashiKDundeeJShahroor-KarniSThielS 2004 Mannose-binding lectin-deficient mice are susceptible to infection with staphylococcus aureus. J Exp Med 199 1379 1390
30. EndoYMatsushitaMFujitaT 2011 The role of ficolins in the lectin pathway of innate immunity. Int J Biochem Cell Biol 43 705 712
31. BrownEJHoseaSWHammerCHBurchCGFrankMM 1982 A quantitative analysis of the interactions of antipneumococcal antibody and complement in experimental pneumococcal bacteremia. J Clin Invest 69 85 98
32. LiJSzalaiAJHollingsheadSKNahmMHBrilesDE 2009 Antibody to the type 3 capsule facilitates immune adherence of pneumococci to erythrocytes and augments their transfer to macrophages. Infect Immun 77 464 471
33. LinTZhouWFarrarCAHargreavesRESheerinNS 2006 Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. Am J Pathol 168 1241 1248
34. KenawyHIAliYMRajakumarKLynchNJKadiogluA 2012 Absence of the lectin activation pathway of complement does not increase susceptibility to pseudomonas aeruginosa infections. Immunobiology 217 272 280
35. WallisRLynchNJ 2007 Biochemistry and genetics of the collectins. KilpatrickD Collagen-related lectins in innate immunity Kerela, India Research Signpost 33 56
36. EndemanHHerpersBLde JongBAVoornGPGruttersJC 2008 Mannose-binding lectin genotypes in susceptibility to community-acquired pneumonia. Chest 134 1135 1140
37. Garcia-LaordenMISole-ViolanJRodriguez de CastroFAspaJBrionesML 2008 Mannose-binding lectin and mannose-binding lectin-associated serine protease 2 in susceptibility, severity, and outcome of pneumonia in adults. J Allergy Clin Immunol 122 368 74
38. ChapmanSJVannbergFOKhorCCSegalSMooreCE 2007 Functional polymorphisms in the FCN2 gene are not associated with invasive pneumococcal disease. Mol Immunol 44 3267 3270
39. YusteJSenATruedssonLJonssonGTayLS 2008 Impaired opsonization with C3b and phagocytosis of streptococcus pneumoniae in sera from subjects with defects in the classical complement pathway. Infect Immun 76 3761 3770
40. TsujimuraMIshidaCSagaraYMiyazakiTMurakamiK 2001 Detection of serum thermolabile beta-2 macroglycoprotein (hakata antigen) by enzyme-linked immunosorbent assay using polysaccharide produced by aerococcus viridans. Clin Diagn Lab Immunol 8 454 459
41. KadiogluAGinglesNAGrattanKKerrAMitchellTJ 2000 Host cellular immune response to pneumococcal lung infection in mice. Infect Immun 68 492 501
42. Sa-LeaoRNunesSBrito-AvoAFrazaoNSimoesAS 2009 Changes in pneumococcal serotypes and antibiotypes carried by vaccinated and unvaccinated day-care centre attendees in portugal, a country with widespread use of the seven-valent pneumococcal conjugate vaccine. Clin Microbiol Infect 15 1002 1007
43. FischerMBMaMGoergSZhouXXiaJ 1996 Regulation of the B cell response to T-dependent antigens by classical pathway complement. J Immunol 157 549 556
44. EndoYMatsushitaMFujitaT 2011 The role of ficolins in the lectin pathway of innate immunity. Int J Biochem Cell Biol 43 705 712
45. LynchNJRoscherSHartungTMorathSMatsushitaM 2004 L-ficolin specifically binds to lipoteichoic acid, a cell wall constituent of gram-positive bacteria, and activates the lectin pathway of complement. J Immunol 172 1198 1202
46. SteffensenRHoffmannKVarmingK 2003 Rapid genotyping of MBL2 gene mutations using real-time PCR with fluorescent hybridisation probes. J Immunol Methods 278 191 199
47. YangYLhottaKChungEKEderPNeumairF 2004 Complete complement components C4A and C4B deficiencies in human kidney diseases and systemic lupus erythematosus. J Immunol 173 2803 2814
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2012 Číslo 7
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- The Lectin Pathway of Complement Activation Is a Critical Component of the Innate Immune Response to Pneumococcal Infection
- Gastrointestinal Cell Mediated Immunity and the Microsporidia
- Polydnaviruses as Symbionts and Gene Delivery Systems
- Evidence for Antigenic Seniority in Influenza A (H3N2) Antibody Responses in Southern China